Cargando…

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies

SIMPLE SUMMARY: Ewing Sarcoma treatment is traditionally based on chemotherapy, surgery, and radiotherapy. Although these standard of care regimens are efficient at early disease stages, many patients fail to respond appropriately, which has prompted the search for more efficacious and specific trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Molina, Sara, Figuerola-Bou, Elisabet, Sánchez-Margalet, Víctor, de la Cruz-Merino, Luis, Mora, Jaume, de Álava Casado, Enrique, García-Domínguez, Daniel José, Hontecillas-Prieto, Lourdes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658520/ https://www.ncbi.nlm.nih.gov/pubmed/36358891 http://dx.doi.org/10.3390/cancers14215473

Ejemplares similares

RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
por: Sánchez-Molina, Sara, et al.
Publicado: (2020)

Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1
por: García-Domínguez, Daniel J., et al.
Publicado: (2022)

Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
por: García-Domínguez, Daniel J., et al.
Publicado: (2021)

RING1B contributes to Ewing sarcoma development by repressing the Na(V)1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein
por: Hernandez-Muñoz, Inmaculada, et al.
Publicado: (2016)

An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis
por: García-Domínguez, Daniel J., et al.
Publicado: (2020)

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
por: García-Domínguez, Daniel Jose, et al.
Publicado: (2018)

Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
por: García-Domínguez, Daniel J., et al.
Publicado: (2022)

Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
por: Sánchez-León, María Luisa, et al.
Publicado: (2023)

Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape
por: Salguero-Aranda, Carmen, et al.
Publicado: (2020)

EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1
por: Sáinz-Jaspeado, Miguel, et al.
Publicado: (2013)

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2015)

Human EWS-FLI protein recapitulates in Drosophila the neomorphic functions that induce Ewing sarcoma tumorigenesis
por: Molnar, Cristina, et al.
Publicado: (2022)

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2017)

Moving forward
por: Li, Li
Publicado: (2020)

Obesity and Risk for Lymphoma: Possible Role of Leptin
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2022)

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2020)

Healthy ageing: moving forward
por: Beard, John R, et al.
Publicado: (2017)

LHC Moves forward
Publicado: (1998)

Moving Education Forward
por: Lewitter, Fran
Publicado: (2007)

BJC moves forward
por: Weiss, R A
Publicado: (2002)

Moving Forward into the Future
por: Wang, Jeffrey C., et al.
Publicado: (2016)

HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2017)

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
por: Mora, J, et al.
Publicado: (2017)

Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion
por: Ali Khan, Asrar, et al.
Publicado: (2021)

IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis
por: Martins, Ana Sofia, et al.
Publicado: (2011)

Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin
por: García-Santos, G, et al.
Publicado: (2012)

eCAM: Moving Forward
por: Cooper, Edwin L.
Publicado: (2007)

Implementing the Vision and Moving Forward
por: Posner, Samuel F.
Publicado: (2009)

Ophthalmic Genetics: Moving Forward
por: Abu-Amero, Khaled K.
Publicado: (2011)

Moving Education Forward, Again!
por: Lewitter, Fran
Publicado: (2013)

Moving forward for the girl child
por: Sule, Supriya
Publicado: (2012)

Looking Back, Moving Forward
Publicado: (2014)

Protein pyrophosphorylation: moving forward
por: Saiardi, Adolfo
Publicado: (2016)

Cancer epigenetics: Moving forward
por: Nebbioso, Angela, et al.
Publicado: (2018)

Antimicrobial resistance – moving forward?
por: Lomazzi, Marta, et al.
Publicado: (2019)

Reflecting back to move forward
por: Sorge, Justin
Publicado: (2019)

Moving Forward with the New Normal
Publicado: (2020)

COVID19 — Moving forward()
por: Waddington, Gordon S.
Publicado: (2020)

Ventilator sharing moves forward
Publicado: (2020)

Moving forward with an imperfect vaccine
por: Pezzoli, Lorenzo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1mjd4prb0nm91l7cl5dkd7tpi